This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Illicit marijuana providers don’t ask for or check for ID, but licensed businesses most certainly do.” The post Colorado: Compliance Check Data Confirms That Retailers Aren’t Selling Marijuana to Minors appeared first on NORML. “Regulation works.
Jobs in the state-licensed cannabis industry rose 15 percent during the past 12 months, and the industry now employs over 243,000 full-time workers, according to data compiled by Leafly.com. Additional information is available in the NORML fact-sheet , ‘Marijuana Regulation: Impact on Health, Safety, Economy.’
The state-licensed cannabis industry gained over 64,000 new employees in 2018, and now employs over 200,000 full-time workers, according to data compiled by Whitney Economics and the online content provider Leafly.com. The full report is available online here.
According to research by real estate data company, Clever , property values rose by $17,113 more in states where recreational cannabis is legal, compared to states where it’s illegal or just legal at the medicinal level. Clever combined data from Zillow, the U.S. New businesses, tourism, and jobs all contribute to the increase.
There is no data showing that there are pervasive health or safety issues in the cannabis industry. The cannabis industry is heavily regulated and the testing programs are unlike the public safety regulations for any commodity in the world.
Building the bridge between brands and the marketplace through testing and the importance of good data. If left to their own devices in Cannabis, a mixed bag of state regulations will continue to confuse the market as they rush to implement policies that are challenging for business and almost impossible for the consumer to understand.
– Drug Demonstrates Efficacy and Safety in Advanced Prostate Cancer Patients. The poster presentation of the data was by Dr. Scott Tagawa , a Professor of Medicine & Urology at Weill Cornell Medicine and an AIkido Pharma Scientific Advisory Board member. – Phase 2 Trial Underway. AIkido Pharma Inc.:
Earlier this month, the FDA released a seven-page plan to accelerate its research into the safety of cannabis-derived products. Piloting market surveillance tools to monitor unapproved cannabis-derived products and “identify potential safety issues before the issues become mainstream.”
New data shows MYMD-1 has key differentiators and capabilities compared to existing TNF inhibitor drugs. BALTIMORE–(BUSINESS WIRE)– MyMD Pharmaceuticals, Inc. Data also demonstrated that none of the biological drugs selected for the comparison study proved to be anti-proliferative to any of the primary cell types assessed.
The data tool can be found on the DCC website here: [link]. The interactive map shows 44 percent of cities and counties allow the licensing of at least one cannabis business type, while 56 percent of cities and counties prohibit the licensing of all cannabis business types. SACRAMENTO, Calif.–( Tweet this.
This partnership with WSU and Qwibil will help us research the safety and efficacy of cannabis as medicine for our patients’ use.”. Jake Felice, a naturopathic medicine practitioner who consults for cannabis businesses in Washington state seeking medicinal approval, said any data collection system for patients should be far-reaching.
Intended to protect New York’s legal cannabis consumers, the state intervention dealt a big punch to cannabis business activities. As activities sluggishly pick up, affected farmers and cannabis-related businesses are counting their losses from the ban on their operations.
Despite its multi-year process of assessing potential exceptions from the Drug Preclusion and evaluating the safety and science of CBD, the FDA has not changed its prohibitive approach. SafetyData Matters. However, the plain language of the Drug Preclusion, supporting case law ( see Pharmanex, Inc. Shalala , 35 F.
The Food and Drug Administration (“FDA”) had a busy Monday this week. On November 25, the agency issued warning letters to 15 businesses selling hemp-derived CBD (“Hemp-CBD”) products as unapproved drugs. The third point focuses on questions that remain about the safety of Hemp-CBD. Warning Letters. Consumer Update. Conclusion.
–(BUSINESS WIRE)– #IGC –(NYSE American: IGC), India Globalization Capital, Inc. (“IGC” IGC” or the “Company”) today announced positive primary endpoint data for its Phase 1 clinical trial for IGC-AD1, which is a proprietary cannabinoid-based investigational new drug candidate for patients who have Alzheimer’s disease.
This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”. Licensing, Agents, and Equity.
Quest Diagnostics started analyzing yearly workplace drug testing data 25 years ago in 1988, and the result of their recent study was published on May 18. However, it is important to note that Quest Diagnostics amphetamines data does not separate prescribed medications like Adderall from illicit drug use. in 2021 and 4.3%
The initial shipment is designated to be used by the Clinic in a pilot run in preparation for the previously announced study , based out of the United Kingdom, on the safety and efficacy of cannabis and hemp for the treatment of patients suffering from chronic pain. About RYAH Group, Inc. RYAH Group, Inc.
Charlotte’s Web took the unusual step of issuing a public response to the refusals, available here , with a link to the company’s also public letter to the FDA here , which responds directly to the agency’s criticisms of the data provided and alleging factual inaccuracies in its response. Still About Safety. Not About Enforcement.
The Cannabis Transporter Licensee Delivery Interruption Procedure stated, “All product listed on a transporter manifest must be delivered to the licensed cannabis business identified on the manifest on the same day the product was manifested for delivery. Product cannot be held overnight by licensed cannabis transporters.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
The problem also extends to cannabis businesses that are actively seeking out testing laboratories that will give them the testing results they desire in terms of contents and potency-even if it is inaccurate. . Their statements also included something to likes of an employee stealing data and then contacting the regulators.
There are five important “categories,” that require company leaders’ utmost focus and attention as they launch a compliant cannabis business in a newly legal state. Non-compliant businesses face the risk of being shut down and attract negative attention to the cannabis industry. Cutting across these categories is the team. Real Estate.
In March, last year the US Food and Drug Administration (FDA) requested specific data on liver toxicity data after saying it believed from CBD use posed ‘real risks’ to human health. Data To Be Used In UK . UK Requires CBD Safety Evidence. It will allow us to differentiate ourselves from the people that don’t.
But for now, the developers are focused on creating a training that emphasizes compassionate response, de-escalation, and the safety and well-being of individuals having a challenging time with a psychedelic experience.
–(BUSINESS WIRE)– PSI Labs , an Ann Arbor, Michigan-based ISO 17025 accredited Safety Compliance Facility that provides essential cannabis testing services, today announced its expansion into Southern California with the acquisition of pH Solutions, LLC. MONROVIA, Calif.–(BUSINESS About PSI Labs. Contacts.
. … An association of marijuana testing labs is calling on the state to release unredacted data from Nevada’s seed-to-sale tracking system amid assertions that certain unidentified labs are inflating THC content readings and giving fewer samples a failing grade in an apparent attempt to attract more business.
The FDA also published a revised Consumer Update detailing safety concerns about CBD products more broadly. This includes ongoing work to obtain and evaluate information to address outstanding questions related to the safety of CBD products, while maintaining the agency’s rigorous public health standards. Sunflora Inc. ,
–(BUSINESS WIRE)–The Travelers Institute , the public policy division of The Travelers Companies, Inc. Our upcoming lineup covers a wide range of topics that are relevant to both individuals and businesses – from politics and new legislation to public health issues, cybersecurity and technology advancements,” said Woodward.
The Core Business delivered strong organic growth 13 in H1 2021 (17% year-on-year) despite some of Eurofins’ businesses remaining affected by lockdowns during H1 2021. We thus provide comparison with the pre-pandemic period of H1 2019 as an additional data point. for the three historic TIC leaders.
–(BUSINESS WIRE)– #AD –India Globalization Capital, Inc. (“IGC”) The Data and Safety Monitoring Committee (“DSMC”) for IGC’s clinical trial, having reviewed the data obtained through Cohort 1 and Cohort 2, recommended progressing to Cohort 3, which consists of administering three doses per day.
Not only this, but Gaize recently completed the largest clinical trial into cannabis impairment , and the results are set to transform the realm of workplace and road safety. In what way(s) do you feel that your science-backed real-time cannabis impairment detection device will have an impact on road and workplace safety?
Those policy areas include public safety concerns, youth prevention, minority access to the industry, and national standards on product testing and pesticides. The group plans to compile data and research, and to release white papers on these policy issues that can be used to inform lawmakers. Read More @ Politico].
–(BUSINESS WIRE)–IRI: Prepared Foods New Products Conference. . WHAT: During the session, “ Cannabis Moves Toward the Mainstream ,” Nielsen will share IRI and BDSA’s predictions for mainstream market opportunities, cannabis ingredients, product development, labeling and safety. . . WHEN: Sept. 14, 2021, from 11:00 a.m.
–(BUSINESS WIRE)– $MRNS #MarinusPharma — Marinus Pharmaceuticals, Inc. Extended Duration Safety and Efficacy of Adjunctive Ganaxolone Treatment in Patients with CDKL5 Deficiency Disorder: 8-Month Minimum Open-Label Extension Follow-up. Webcast to be held Monday, December 6 at 1:00 p.m. ET (12:00 p.m. RADNOR, Pa.–(BUSINESS
hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.
The Rules establish the recreational cannabis industry in New Jersey and allow the CRC to begin licensing businesses as soon as possible. Conditional license applications are prioritized over annual license applications to prioritize small business ownership.
The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.
A group of Colorado lawmakers wants to increase oversight of the state’s marijuana businesses, but the cannabis industry is ready to fight the proposal. ” The MED conducted 604 underage compliance checks at dispensaries in 2019, according to department data, but that number dropped to 118 in 2020 and 80 in 2021.
FDA continually asked the companies for meetings and safetydata about their products containing full-spectrum hemp extract. After complying with FDA’s requests, these companies saw FDA reject their NDI notifications—disregarding published peer-reviewed toxicology studies and years’ worth of real-world safety evidence.
These results raise safety and efficacy concerns. “Ensuring accurate CBD dosage labelling is important for consumer safety and efficacy,” said Dr. Guy Setton , CEO of GemmaCert Ltd. TEL AVIV, Israel , Feb. According to new research by Grand View Research (2019), the global CBD market is forecasted to reach US$ 9.69
–(BUSINESS WIRE)–cbdMD, Inc. The intended purpose of these studies is to provide data that will feed into the cbdMD Therapeutics research pipeline. This safetydata will support the ensuing preclinical trials in humans to explore the efficacy of the cannabinoids. CHARLOTTE, N.C.–(BUSINESS
DENVER–(BUSINESS WIRE)– $CBD.U #CBD Built on a foundation of regulatory compliance and human safety, HempFusion’s diverse product portfolio comprises 48 SKUs including tinctures, proprietary FDA Drug Listed Over-The-Counter (OTC) Topicals, Doctor/Practitioner Lines and more. CBD –HempFusion Wellness Inc.
hemp farmers are denied profitable markets for their crops, while unregulated products continue to proliferate, with no safeguards for public health and safety. With regard to adding CBD to food and beverages, FDA maintains that the data currently available raises safety concerns and encourages parties to share relevant information with FDA.
We organize all of the trending information in your field so you don't have to. Join 14,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content